DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection
- PMID: 11435586
- PMCID: PMC114434
- DOI: 10.1128/JVI.75.15.7059-7066.2001
DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection
Abstract
Hepatitis C virus (HCV) poses a worldwide health problem in that the majority of individuals exposed to HCV become chronically infected and are predisposed for developing significant liver disease. DNA microarray technology provides an opportunity to survey transcription modulation in the context of an infectious disease and is a particularly attractive approach in characterizing HCV-host interactions, since the mechanisms underlying viral persistence and disease progression are not understood and are difficult to study. Here, we describe the changes in liver gene expression during the course of an acute-resolving HCV infection in a chimpanzee. Clearance of viremia in this animal occurred between weeks 6 and 8, while clearance of residual infected hepatocytes did not occur until 14 weeks postinfection. The most notable changes in gene expression occurred in numerous interferon response genes (including all three classical interferon antiviral pathways) that increased dramatically, some as early as day 2 postinfection. The data suggest a biphasic mechanism of viral clearance dependent on both the innate and adaptive immune responses and provide insight into the response of the liver to a hepatotropic viral infection.
Figures



Similar articles
-
Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA.Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):11223-8. doi: 10.1073/pnas.1101939108. Epub 2011 Jun 20. Proc Natl Acad Sci U S A. 2011. PMID: 21690403 Free PMC article.
-
The chimpanzee model of hepatitis C virus infections.ILAR J. 2001;42(2):117-26. doi: 10.1093/ilar.42.2.117. ILAR J. 2001. PMID: 11406714 Review.
-
Hepatic transcriptome analysis of hepatitis C virus infection in chimpanzees defines unique gene expression patterns associated with viral clearance.PLoS One. 2008;3(10):e3442. doi: 10.1371/journal.pone.0003442. Epub 2008 Oct 17. PLoS One. 2008. PMID: 18927617 Free PMC article.
-
Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease.Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15661-8. doi: 10.1073/pnas.202608299. Epub 2002 Nov 19. Proc Natl Acad Sci U S A. 2002. PMID: 12441397 Free PMC article.
-
Innate and adaptive immune responses in HCV infections.J Hepatol. 2014 Nov;61(1 Suppl):S14-25. doi: 10.1016/j.jhep.2014.06.035. Epub 2014 Nov 3. J Hepatol. 2014. PMID: 25443342 Review.
Cited by
-
Organ system view of the hepatic innate immunity in HCV infection.J Med Virol. 2016 Dec;88(12):2025-2037. doi: 10.1002/jmv.24569. Epub 2016 May 13. J Med Virol. 2016. PMID: 27153233 Free PMC article. Review.
-
Stealth and cunning: hepatitis B and hepatitis C viruses.J Virol. 2005 Aug;79(15):9369-80. doi: 10.1128/JVI.79.15.9369-9380.2005. J Virol. 2005. PMID: 16014900 Free PMC article. Review. No abstract available.
-
Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I.J Virol. 2005 Mar;79(5):2689-99. doi: 10.1128/JVI.79.5.2689-2699.2005. J Virol. 2005. PMID: 15708988 Free PMC article.
-
Using the power of innate immunoprofiling to understand vaccine design, infection, and immunity.Hum Vaccin Immunother. 2023 Dec 15;19(3):2267295. doi: 10.1080/21645515.2023.2267295. Epub 2023 Oct 26. Hum Vaccin Immunother. 2023. PMID: 37885158 Free PMC article. Review.
-
HCV innate immune responses.Viruses. 2009 Dec;1(3):1073-88. doi: 10.3390/v1031073. Epub 2009 Nov 30. Viruses. 2009. PMID: 21994583 Free PMC article.
References
-
- Ahmed A, Keeffe E B. Treatment strategies for chronic hepatitis C: update since the 1997 National Institutes of Health Consensus Development Conference. J Gastroenterol Hepatol. 1999;14:S12–S18. - PubMed
-
- Alter H, Seeff L. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis. 2000;20:17–35. - PubMed
-
- Anonymous. Hepatitis C: global prevalence. Wkly Epidemiol Rec. 1997;72:341–344. - PubMed
-
- Artini M, Natoli C, Tinari N, Costanzo A, Marinelli R, Balsano C, Porcari P, Angelucci D, D'Egidio M, Levrero M, Iacobelli S. Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patients. J Hepatol. 1996;25:212–217. - PubMed
-
- Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol. 1997;15:675–705. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical